Coronavirus (COVID-19)

As COVID-19 cases increase along with spread of the more transmissible Delta variant, the effectiveness of COVID-19 vaccines continues to be an important topic. A new KFF analysis looks at COVID-19 vaccine “breakthrough cases,” when fully vaccinated individuals become infected, as well as hospitalizations and deaths, to see which states…

This fact sheet reviews what employers can and cannot do under current rules and guidance to require or encourage their workers to get vaccinated against COVID-19.

We reviewed the websites and other official state sources for all 50 states and D.C. to see which are providing data on COVID-19 breakthrough cases, hospitalizations and deaths, how regularly, and what those data may tell us.

This data note examines state-level data on COVID-19 cases and deaths in long-term care facilities through June prior to the recent rise in cases and deaths nationally linked to the spread of the Delta variant. It finds long-term care deaths down 96% from their peak in December as the nation’s vaccination effort began.

Analysis of characteristics of children under 12 in the U.S. to help inform COVID-19 vaccination efforts when they become eligible.

A new KFF analysis finds that only 1% of those in low-income countries have received at least one vaccine dose compared to 51% in high-income countries, highlighting the substantial vaccine inequities around the world. The analysis examines these inequities by country income level and by region, finding large differences for…

This analysis looks at global COVID-19 vaccination efforts by income-level and region to assess the equity gap in both vaccination coverage and rates of administration. Overall, we find that low-income countries and countries are lagging behind, and based on current rates, are unlikely to meet global vaccination targets.

This brief reviews initial 2022 premium rate filings for Marketplace-participating individual market insurers in 13 states and the District of Columbia. Most expect health utilization patterns to return to pre-pandemic levels and therefore not factoring in any impact on their 2022 premiums.

After a tumultuous year of unpredictable COVID-19 changes to utilization and spending, a review of early rate filings for individual market insurers participating in the Affordable Care Act Marketplace finds that most are expecting a return to normal in 2022 without the pandemic playing a large role. The review of…

A new KFF COVID-19 Vaccine Monitor report finds that people who were initially hesitant to get a vaccine in January but ultimately did so often say that family, friends and their personal doctors helped change their minds. The report features a second round of interviews with a nationally representative sample…